Get my own profile
Public access
View all26 articles
1 article
available
not available
Based on funding mandates
Co-authors
- Peter GoosKU LeuvenVerified email at biw.kuleuven.be
- Martina VandebroekKU LeuvenVerified email at kuleuven.be
- Jeroen LuytenLeuven Unit for Health Technology Assessment Research, KU LeuvenVerified email at kuleuven.be
- Bradley JonesPrincipal at AdsurgoVerified email at adsurgo.com
- Philippe BeutelsProfessor at Vaccine & Infectious Disease Institute, University of Antwerp, BelgiumVerified email at uantwerpen.be
- Guido ErreygersProfessor of Economics, University of AntwerpVerified email at uantwerpen.be
- Ann VerhetselProfessor of Economic Geography, University of AntwerpVerified email at uantwerpen.be
- Lander WillemUniversity of AntwerpVerified email at uantwerpen.be
- Frederik VerelstDirector, Vaccines Value Evidence / Health Outcomes, GSKVerified email at gsk.com
- G. Ardine de WitUniversity Medical Centre Utrecht & National Institute of Public Health, the NetherlandsVerified email at rivm.nl
- Niek MouterAssociate professor Delft University of TechnologyVerified email at tudelft.nl
- Sandy TubeufUniversité Catholique de LouvainVerified email at uclouvain.be
- Eddy Van de VoordeUniversiteit AntwerpenVerified email at uantwerpen.be
- Job van ExelErasmus University RotterdamVerified email at eshpm.eur.nl
- Toon ZijlstraSenior ResearcherVerified email at minienw.nl
- Maarten van WijhePost-doctoral fellow, University of RoskildeVerified email at ruc.dk
- Marion CollewetLeiden UniversityVerified email at law.leidenuniv.nl
- Daniel Palhazi CuervoSINTEF DigitalVerified email at sintef.no
- Albert Jan van HoekHealth economist / Infectious disease modeller, RIVMVerified email at rivm.nl
- Jeroen CantUniversity of AntwerpVerified email at uantwerpen.be